Nanopass Technologies Ltd.

Nanopass Technologies Ltd. is a pharmaceutical startup based in Israel. The company's slogan, "Delivering Precision," reflects its dedication to advancing healthcare through cutting-edge technology. NanoPass is known for pioneering revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures with its proprietary MicronJet™ intradermal delivery product platform. The company's flagship product, MicronJet, has gained recognition as the most advanced hollow microneedle device available today, with more than 50 clinical studies supporting its excellent performance. Backed by prominent Israeli and US investors including IHCV, Ofer Hi-Tech, D-Partners, WFD Ventures, and Elcam Medical, NanoPass recently closed a new round of financing, led by Israel Health Care Ventures (IHCV). This $6.50M Series B investment at 18 February 2007 underlines the confidence of investors in the company's innovative approach. NanoPass is further solidifying its position by engaging in joint clinical development with top pharmaceutical companies to demonstrate the benefits of its technology for various indications, showcasing its commitment to the future of healthcare.